Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
51m
on MSN
Merck & Co. (MRK): Strong Growth Driven by Keytruda and New Vaccine Approvals
We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...
FiercePharma
43m
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer ...
Pharmaceutical Technology
32m
MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win
A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
Retiring after 15 seasons
La Nina could arrive soon
PG&E shuts power off
Sells for $9M at auction
NYC giant pigeon sculpture
Donations drop 15%
Musk's first Trump event
Teen tobacco use falls
OK classroom Bible suit
School shooting indictment
Texas AG sues doctor
988 Lifeline georouting
Sued for alleged misconduct
US charges ex-Indian spy
TX top court halts execution
Space export curbs eased
Evidence delay bid denied
Eases voting rules
Dow closes at record high
Teen anti-sextortion push
‘Full Self-Driving’ probe
Colsen fire pits recalled
Afghan man denied release
Hyundai recalls vehicles
Three Americans detained
Nevada US Senate debate
Files for US IPO
Feedback